Nijhawan Pardeep's Form 4 filing
Edesa Biotech, Inc. (EDSA) · filed Mar 14, 2022
- Accession no.
- 0001654954-22-003095
- Filed
- Mar 14, 2022, 1:59 PM ET
- Trade date
- Mar 11, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $21.7K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nijhawan PardeepCIK 0001777962 | Director, Officer (Chief Executive Officer), 10% Owner |
| Pardeep Nijhawan Medicine Professional CorpCIK 0001780021 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2022 | Common Shares | PPurchaseAcquired | +2,000 | $3.18 | +$6,357.6 | 550,812 | Direct | |
| Mar 11, 2022 | Common Shares | PPurchaseAcquired | +5,000 | $3.06 | +$15,294.5 | 555,812 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.